Voriconazole

CHEMBL638 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
349.3 g/mol
LogP
1.5
Phase
4

This broad-spectrum antifungal medication is used to treat serious and potentially life-threatening fungal infections, particularly invasive aspergillosis and certain other mold and yeast infections in immunocompromised patients such as those undergoing bone marrow transplants. It is available in both oral and intravenous forms and works by blocking a key enzyme in the fungal cell membrane synthesis pathway. It interacts with many medications and can cause visual disturbances, liver toxicity, and sun sensitivity.

分子量

349.3100 g/mol

LogP

1.50

TPSA

76.70 Ų

リピンスキーの五則

適合

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F

InChI

InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1

Molecular Formula

C16H14F3N5O

HBD / HBA

1 / 8

回転可能結合数

5

重原子数

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

This broad-spectrum antifungal medication is used to treat serious and potentially life-threatening fungal infections, particularly invasive aspergillosis and certain other mold and yeast infections in immunocompromised patients such as those undergoing bone marrow transplants. It is available in both oral and intravenous forms and works by blocking a key enzyme in the fungal cell membrane synthesis pathway. It interacts with many medications and can cause visual disturbances, liver toxicity, and sun sensitivity.

Yes, Voriconazole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL638. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 71616. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.